Clinical Trial Update: A Phase I Trial of AZD3965 in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Phase I trial of AZD3965 in adults with advanced cancer, including diffuse large B-cell lymphoma and Burkitt lymphoma, completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• Solid Tumor

Drugs mentioned

• AZD3965 (AZD3965)

Snippet

Sponsor: Cancer Research UK | Conditions: Adult Solid Tumor, Diffuse Large B Cell Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2022-04-11